Understanding Cannabidiol (CBD) - Part 4

Photo Credit: Medical Marijuana Inc.

Photo Credit: Medical Marijuana Inc.

We will continue our discussion of conditions that can benefit from the use of CBD.

CBD can treat multiple sclerosis (MS) by reducing inflammation, providing neuroprotection and limiting the diseases progression. It also reduces MS symptoms like spasticity and neuropathic pain. Cannabis can fight obesity, and CBD specifically decreases body weight gain and reduces lipid levels. Because of CBD's neuroprotective properties, it supports the health of neural cells mitochondria and prevents neurodegeneration. In this way, CBD treatments improved well being and quality of life scores for those who suffer from Parkinson's disease. CBD might help PTSD sufferers by interacting with the CB1 and CB2 receptors so that it modulates the release of neurotransmitters, increases a sense of pleasure, and initiates the alternation of memory processes. CBD also blocks the continuous retrieval of the traumatic event, thereby enhancing its extension and reducing its associated anxiety.

Not only does CBD have anxiolytic and antipsychotic properties, but trials have also show that CBD is a safe and well-tolerated alternative treatment for schizophrenia. Patients who suffer from spinal cord diseases or damage can witness an improvement in bladder control muscle spasms, and spasticity with the use of CBD. CBD also stimulates a neuroprotective response that limits damage when it is administered shortly after a spinal cord injury and improves motor scores following the injury. Similarly, CBD protects neurons and astrocytes from damage when administered shortly after a stroke, which leads to improved functional, histological, biochemical, and neurobehavior recovery. Lastly, CBD's neuropotective effects limit brain damage following traumatic brain injury. 

This concludes our series on CBD and the therapeutic benefits it has for a multitude of conditions. This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.